Anti-FVIII antibodies in Black and White hemophilia A subjects: do F8 haplotypes play a role?

The most common complication in hemophilia A (HA) treatment, affecting 25% to 30% of patients with severe HA, is the development of alloimmune inhibitors that foreclose the ability of infused factor VIII (FVIII) to participate in coagulation. Inhibitors confer significant pathology on affected indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratt, Kathleen P., Gunasekera, Devi, Vir, Pooja, Tan, Siyuan, Pierce, Glenn F., Olsen, Cara, Butenas, Saulius, Mann, Kenneth G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471934/
https://www.ncbi.nlm.nih.gov/pubmed/36459498
http://dx.doi.org/10.1182/bloodadvances.2021004909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471934/
https://www.ncbi.nlm.nih.gov/pubmed/36459498
http://dx.doi.org/10.1182/bloodadvances.2021004909

Ejemplares similares